Sunho Biologics, Inc.
Rachunek Zysków i Strat
| index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
| Rok finansowy |
2022 |
2023 |
2023 |
2023 |
2024 |
2024 |
2024 |
2024 |
| Kwartał |
Q4 |
Q1 |
Q2 |
Q4 |
Q1 |
Q2 |
Q3 |
Q4 |
| Data |
2022-12-31 |
2023-03-31 |
2023-06-30 |
2023-12-31 |
2024-03-31 |
2024-06-30 |
2024-09-30 |
2024-12-31 |
| Przychód (mln) |
0 |
3 |
3 |
2 |
0 |
0 |
0 |
0 |
| Przychód Δ kw/kw |
0.0% |
0.0% |
0.0% |
0.0% |
-77.91% |
-99.37% |
-100.00% |
-100.00% |
| Marża brutto |
100.0% |
100.0% |
100.0% |
100.0% |
100.0% |
100.0% |
0.0% |
0.0% |
| Koszty i Wydatki (mln) |
17 |
29 |
29 |
13 |
26 |
26 |
24 |
24 |
| EBIT (mln) |
-16 |
-26 |
-26 |
-11 |
-26 |
-26 |
-24 |
-24 |
| EBIT Δ kw/kw |
0.0% |
0.0% |
0.0% |
0.0% |
60.5% |
2.3% |
-6.43% |
128.7% |
| EBIT (%) |
-19180.23% |
-862.33% |
-862.33% |
-528.56% |
-139315.79% |
-139315.79% |
0.0% |
0.0% |
| Przychody fiansowe (mln) |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Koszty finansowe (mln) |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Amortyzacja (mln) |
2 |
2 |
2 |
2 |
2 |
2 |
2 |
2 |
| EBITDA (mln) |
-15 |
-24 |
-24 |
6 |
-25 |
-25 |
-23 |
-23 |
| EBITDA(%) |
-16994.19% |
-808.92% |
-808.92% |
279.0% |
-130465.79% |
-130465.79% |
0.0% |
0.0% |
| NOPLAT (mln) |
-19 |
-31 |
-31 |
-57 |
-18 |
-18 |
-22 |
-22 |
| Podatek (mln) |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Zysk Netto (mln) |
-19 |
-31 |
-31 |
-57 |
-18 |
-18 |
-22 |
-22 |
| Zysk netto Δ kw/kw |
0.0% |
0.0% |
0.0% |
0.0% |
-2.99% |
-41.33% |
-28.62% |
-61.70% |
| Zysk netto (%) |
-21622.09% |
-1024.82% |
-1024.82% |
-2860.51% |
-94939.47% |
-94939.47% |
0.0% |
0.0% |
| EPS |
-0.2 |
-0.34 |
-0.34 |
-0.61 |
-0.17 |
-0.17 |
-0.14 |
-0.14 |
| EPS (rozwodnione) |
-0.2 |
-0.34 |
-0.34 |
-0.61 |
-0.17 |
-0.17 |
-0.14 |
-0.14 |
| Ilośc akcji (mln) |
91 |
92 |
92 |
94 |
106 |
106 |
152 |
152 |
| Ważona ilośc akcji (mln) |
91 |
92 |
92 |
94 |
106 |
106 |
152 |
152 |
| Waluta |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |